A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.

Fonteneau C, Tamayo Z, Price A, Pan L, Afriyie-Agyemang Y, Agrawal S, Butler A, Cail C, Calkins M, Chakilam AR, Forselius-Bielen K, Fram G, Frazier A, Gil R, Govil P, Gray DL, Grinband J, Gur RC, Haubold NK, Heffernan Z, Heneks M, Kegeles L, Kohler C, Lin C, Lu J, Mayer M, Pham P, Perlman G, Rahmati M, Ranganathan M, Santamauro NP, Schutte CW, Selloni A, Van Snellenberg J, Surti T, Wolf DH, Zharyy C, TRANSCENDS Group, Abi-Dargham A, Gur RE, Lieberman JA, Kantrowitz JT, Anticevic A, Cho YT, Krystal JH

Open source

DOI
10.1016/j.jpsychires.2025.12.020
Published
2026 Mar
Container
Journal of psychiatric research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jpsychires.2025.12.020,
  title = {A translational neuroscience \& computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.},
  author = {Fonteneau C and Tamayo Z and Price A and Pan L and Afriyie-Agyemang Y and Agrawal S and Butler A and Cail C and Calkins M and Chakilam AR and Forselius-Bielen K and Fram G and Frazier A and Gil R and Govil P and Gray DL and Grinband J and Gur RC and Haubold NK and Heffernan Z and Heneks M and Kegeles L and Kohler C and Lin C and Lu J and Mayer M and Pham P and Perlman G and Rahmati M and Ranganathan M and Santamauro NP and Schutte CW and Selloni A and Van Snellenberg J and Surti T and Wolf DH and Zharyy C and TRANSCENDS Group and Abi-Dargham A and Gur RE and Lieberman JA and Kantrowitz JT and Anticevic A and Cho YT and Krystal JH},
  year = {2026},
  journal = {Journal of psychiatric research},
  doi = {10.1016/j.jpsychires.2025.12.020},
  url = {https://doi.org/10.1016/j.jpsychires.2025.12.020}
}

RIS

TY  - JOUR
TI  - A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.
AU  - Fonteneau C
AU  - Tamayo Z
AU  - Price A
AU  - Pan L
AU  - Afriyie-Agyemang Y
AU  - Agrawal S
AU  - Butler A
AU  - Cail C
AU  - Calkins M
AU  - Chakilam AR
AU  - Forselius-Bielen K
AU  - Fram G
AU  - Frazier A
AU  - Gil R
AU  - Govil P
AU  - Gray DL
AU  - Grinband J
AU  - Gur RC
AU  - Haubold NK
AU  - Heffernan Z
AU  - Heneks M
AU  - Kegeles L
AU  - Kohler C
AU  - Lin C
AU  - Lu J
AU  - Mayer M
AU  - Pham P
AU  - Perlman G
AU  - Rahmati M
AU  - Ranganathan M
AU  - Santamauro NP
AU  - Schutte CW
AU  - Selloni A
AU  - Van Snellenberg J
AU  - Surti T
AU  - Wolf DH
AU  - Zharyy C
AU  - TRANSCENDS Group
AU  - Abi-Dargham A
AU  - Gur RE
AU  - Lieberman JA
AU  - Kantrowitz JT
AU  - Anticevic A
AU  - Cho YT
AU  - Krystal JH
PY  - 2026
JO  - Journal of psychiatric research
DO  - 10.1016/j.jpsychires.2025.12.020
UR  - https://doi.org/10.1016/j.jpsychires.2025.12.020
ER  -

APA

C, F., Z, T., A, P., L, P., Y, A., S, A., A, B., C, C., M, C., AR, C., K, F., G, F., A, F., R, G., P, G., DL, G., J, G., RC, G., NK, H., Z, H., M, H., L, K., C, K., C, L., J, L., M, M., P, P., G, P., M, R., M, R., NP, S., CW, S., A, S., J, V. S., T, S., DH, W., C, Z., Group, T., A, A., RE, G., JA, L., JT, K., A, A., YT, C., & JH, K. (2026). A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial.. Journal of psychiatric research. https://doi.org/10.1016/j.jpsychires.2025.12.020

Source records